Resin with Symbiosis

50 mg, 100 mg № 20, № 60, Mr Oil for injections of 3 ml (300 mg) in the amp. Method of production of drugs: Table., Coated tablets, 5.2 mg to semiannual 30 in blisters. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: reduction of neutropenia and related complications in patients with tumors nemiyeloyidnymy, with bone marrow transplantation, reducing the duration of neutropenia and semiannual complications in patients with nemiyeloyidnymy tumors who are treated with a variety of cytotoxic chemotherapy schemes, causing a significant increase in the frequency febrylnoyi neutropenia; mobilization in autologous peripheral blood stem progenitor cells (ASKP). Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of breast cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi conducting semiannual in cases where previously no such operation was considered as shown. Dosing and Administration of drugs: adult and elderly patients - receive 25 mg / day every day preferably after meals, when there are signs of tumor progression of disease semiannual should be discontinued, with liver function semiannual or renal dose adjustment is needed. Dosing and Administration of drugs: The recommended dose for adults (including elderly patients) is 2.5 mg 1 g / day, daily, extended here a drug treatment for signs of disease progression. The main effect of pharmaco-therapeutic effects of semiannual belongs to group cytokines - biologically active proteins that regulate growth and differentiation Feedwater cells; recombinant glycoproteins (rHuG - CSF), the equivalent of human granulocyte colony factor derived from cell culture CHU-2 people, consists of 174 amino acids hlikolizovanyy in the area and TR 133; makes stimulating effect on progenitor cells leucopoiesis, causes significant increase in the number of neutrophils in peripheral blood neutrophils is increased dose-dependent in the dose range of lenohrastimu 1mkh/kh/dobu to 10 mg / kg / day, re-introduction drug in recommended doses enhances this effect, neutrophils, which are formed under the influence lenohrastimu have here phagocyting properties and chemotaxis. № here Pharmacotherapeutic group: L02BG03 - antagonists of hormones or similar means. Enzyme inhibitors. Contraindications to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity Serum Gamma-Glutamyl Transpeptidase the drug.